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Summary 
A  prominent feature of the life cycle of intracellular parasites is the profound morphological 
changes they undergo during development in the vertebrate and invertebrate hosts. In eukary- 
otic  cells,  most cytoplasmic proteins  are  degraded  in  proteasornes.  Here,  we  show  that  the 
transformation in axenic medium of trypomastigotes of Trypanosoma  cruzi into amastigote-like 
orgamsms, and the intracellular development of the parasite from amastigotes into trypomasti- 
gotes, are prevented by lactacystin, or by a peptide aldehyde that inhibits proteasome function. 
Clasto-lactacystin, an inactive analogue of lactacystin, and cell-permeant peptide aldehyde in- 
hibitors of T. cruzi cysteine proteinases have no effect. We have also identified the 20S protea- 
somes from T. cruzi as a target oflactacystin in vivo. Our results document the essential role of 
proteasomes in the stage-specific transformation of a protozoan. 
I 
nfection  by  Trypanosoma  cruzi,  the  causative  agent  of 
Chagas'  disease,  is  initiated  by  metacyclic  trypomasti- 
gotes present  in  the  feces of triatomine bugs.  The trypo- 
mastigotes invade host cells and enter the cytoplasm, where 
they transform into  amastigotes. The amastigotes replicate 
and, a few days later, transform back into trypomastigotes, 
rupture  the  host  cells,  and  invade  the  bloodstream  (1). 
Thus, on two occasions during its intracellular stage,  T. cruzi 
undergoes  shape  and volume changes,  restructures  its fla- 
gellum and kinetoplast, and synthesizes new sets  of surface 
molecules. These striking modifications are precisely timed, 
take place in an orderly fashion, and must involve selective 
degradation of cytoplasmic proteins. 
In eukaryotic cells,  most proteins in the  cytoplasm and 
nucleus are degraded not in lysosomes, hut within protea- 
somes, after they are marked for destruction by covalent at- 
tachment of ubiquitin  (Ub) l molecules (2-5).  In addition 
1Abbreviatzons used in this paper: BSA, bovine serum albumin; CAPS, (3- 
[Cyclohexylarmno]-l-Propanesulfonlc acid), Ch-L, Chymotrypsln-hke; 
EDTA, ethylene dl-amino tetra acetic acid; E-64, trans-epoxysuccmyl- 
L-leucylamldo-3-methyl-butane  ethyl ester; FCS, fetal calf  serum; F1TC, 
fluoresceln lsothiocyanate; MES, (2-[N-morphohno]-ethanesulfonlc  aod); 
MG-132, carboxybenzoxyl-leucinyl-leucinyl-leuclnal-H;  PGPH, pepti- 
dylglutamyl peptlde hydrolase; T-L, Trypsin-like;  Ub, ub~qultin. 
to  their  role  in  nonlysosomal  protein  turnover,  protea- 
somes are involved in  specific cellular functions,  includ- 
ing the following: the programmed inactivation of mitotic 
cychns, transcription factors, and transcriptional regulators; 
the elimination of mutated or damaged proteins; and anti- 
gen presentation.  The function  of the proteasomes is also 
tightly  regulated,  and  their  structure  may vary  to  match 
function (6-7). 
The experiments described below were designed to doc- 
ument the participation ofproteasomes in the developmen- 
tal pathways of protozoan parasites.  T.  cruzi has an advan- 
tage  as an  experimental model because its  trypomastigote 
form can be induced to change rapidly into amastigotes in 
axenic  medium.  The  resulting  amastigote-hke  parasites 
cannot  be  distinguished  from intracellular  amastigotes by 
light  or  electron  microscopy,  or  by stage-specific surface 
markers. Thus, in this model, the effects ofprotease inhibi- 
tors on transformation can be studied independently from 
their effect on the cells of the host. 
Materials and Methods 
Cell Lines.  LLC-MK  2 fibroblasts were obtained from Amen- 
can Type Culture Collection,  Rockville, MD (ATCC CCL-7). 
L6E9 myoblasts were a gift of Dr. R. Docampo (Umversxty of I1- 
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1640 medium supplemented with 10% FCS,  100  tzg/ml penicil- 
hn, and streptomycin. 
Reagents.  Protease  inhlbitors  E-64,  E-64d,  Cbz-Phe-Ala- 
FMK, Cbz-(S-BZ)-Cys-Phe-CHN2,  and fluorogenic substrates 
were purchased from Sigma Chemical Co. (St. Lores, MO). Lac- 
tacystin and clasto-lactacystin were synthesized as prewously de- 
scribed  (8,  9).  MG-132  was  from  Proscript,  Inc.  (Cambridge, 
MA). Chromatography columns and resins were from Pharmacia 
Biotech AB (Uppsala, Sweden). 
Inhibition of Trypomastigote Transformation into Amastigotes.  LLC- 
MK  2 cells were infeCted with T. cruzi trypomastigotes, Y strata  (10). 
4 d later, the supernatants  contained more than 95% trypomasti- 
gotes  and  small  number  of amastigotes  or  intermediate  forms. 
Parasite transformation into amastigotes was induced by lowering 
the pH of the incubation medium (11,  12).  To assay for the effect 
of inhibitors in the transformation,  twofold dilunons of each in- 
hibitor were  distributed  m  96-microwell plates.  Dilutions  were 
made with DMEM buffered with 20 mM MES (pH 5.0) contain- 
ing  0.4%  BSA.  Lactacystin  or  clasto-lactacystin,  MG-132,  E-64, 
Cbz-(S-BZ)-Cys-PheqEHN2 and Cbz-Phe-Ala-FMK were pre- 
pared at 200 ~M, and 50 p,1 were added to wells to final dilutions 
of 100-0.78  p,M. Depending on the inhibltors used, DMSO di- 
lutions or medium were used as controls. Trypomastigotes were 
centnfuged (3,000g ×  15 min) and resuspended at 2  ×  107/ml in 
DMEM  (pH  5.0).  50  p~l of this  suspension  was  added  to  each 
well, mixed, and incubated for 4  h  at 37°C in a 5% CO2 atmo- 
sphere.  The plate was centrifuged and the supernatants  were re- 
moved  and  replaced  by  DMEM  (pH  7)  containing  10%  FCS. 
The plates were reincubated overnight at 37°C m  a CO2 incuba- 
tor.  The percentage  of transformed  parasites  was  determined by 
microscopically scoring 200  cells in each well in a blinded fash- 
ion. All experiments were carried out in duphcate. 
FACS  ~ Analysis.  Parasates  (2.5  ×  107) were  transformed  in 
the presence  or absence  of proteinase inhlbitors as described.  At 
the end of the incubation,  parasites were resuspended in 250 }xl 
of DMEM at 4°C, and an equal volume ofmonoclonal antibodies 
2C2  anti-Ssp-4  or 3C9  ant,-Ssp-3  (13)  was added.  The incuba- 
tion  proceeded  for  30  mm  on  ice.  The  suspension  was  then 
centrifuged for 7  rain  at  3,500  rpm  in  a  refrigerated centnfuge 
(Sorvall  I<T6000B),  using  a  horizontal  rotor.  The  supernatant 
was removed, and the parasites were fixed with 4% paraformalde- 
hyde in PBS. After 30 min at 4°C, the fixanve was removed and 
the parasites were washed with 1 ml of cold 0.4% BSA-DMEM. 
The parasites  were  then  incubated  for 30  rain with  anti-mouse 
IgG  conjugated  with  FITC.  The  suspensions  were  centrifuged, 
washed with 0.4% BSA-DMEM, resuspended  in 50  [zl of PBS, 
and  postfixed  with  4%  paraformaldehyde.  The  cell suspensions 
were analyzed in a Becton Dickinson FACScan  ®. 
Inhibition of Development of lntracellular Parasites.  L6E9  myoblasts 
were lrra&ated with 2,000 rads (14) and plated in 4-well Lab-Tek 
rmcrochamber  slides  (NUNC,  Napervllle,  IL).  Trypomamgotes 
were pretreated for 1 h with 10 btM lactacystm or clasto-lactacys- 
tin at 37°C. Parasites were washed twice, resuspended in DMEM, 
and used to infect myoblasts at a parasite  to L6E9 cells rano of 5:1. 
After 2 h lncubatmn at 37°C, trypomastigotes were removed, and 
the L6E9 cells were washed with DMEM. To study the effect of 
inhlbitors on invasion, one set of cells was fixed wath 4% paraformal- 
dehyde in PBS for 30 man. Extracellular trypomastigotes were de- 
tected by lmmunofluoresceuce with a polyclonal antibody to  T. 
cruzi,  and the total number of parasites was determined by stain- 
ing with Hoechst dye (Sigma) after permeabilization of the L6E9 
cells with cold methanol for 10 mlu. The number ofintracellular 
parasites was  calculated by subtracting the extracellular from the 
total parasites  (15). To determine the fate oflactacysnn-treated para- 
sites, the remaining infected cell cultures were reincubated at 37°C. 
At 24, 48, and 72 h, triplicate wells were washed and stained with 
May-Grunwald-Giemsa.  The  slides were  examined  under  light 
microscopy and  the  number  of lntracellular  amastigotes  in  100 
cells was counted. Results are expressed as means +  SD. 
In another set of experiments, we studied the effect of mhibi- 
tors on the transformation of intracellular amastigotes into trypo- 
mastigotes.  Cell cultures were infected with  T.  cruzi trypomasn- 
gotes. 48 h  after infection, the cultures were treated for 2 h  with 
0.75,  1.5, and 3  IzM of lactacystin or clasto-lactacystin. The cul- 
tures were washed and reincubated at 37°C for an additional 2 d, 
when  the first parasite  burst  occurred.  The  culture  supernatants 
were collected and the numbers  of exiting trypomamgotes were 
determined  in  a  Neubauer  chamber.  To  document  further  the 
inhibitory  effect of lactacystin  in the  amastigote/trypomastigote 
transformation,  mfected cultures were lysed 72, 80, 88, and 96 h 
after infection with  a  buffer  containing  3%  n-octylglucopirano- 
side, 50 mM Tris-HC1 (pH 7.4),  0.1  mM EDTA, 20 b~M E-64 
and 5 Dg/ml leupeptin, antipain, and pepstatin. The extracts were 
analyzed for levels of translalidase,  an enzyme expressed in trypo- 
mastigotes, but not in amastigotes (16).  Measurements were made 
in  triplicate  samples,  and  transialidase  activity was  expressed  as 
cpm +  SD. 
Enzymatic Assays.  Proteolync  activity  was  assayed  using  as 
substrate  100  p~M fluorogenic peptides  diluted in 50  mM Tns- 
HCl (pH 7.8).  10  Izl of chromatographic  fractions was added to 
90  b~l of the fluorogenic peptide,  and the mixtures incubated  at 
37°C for 30 mm before quenching with 200  D1 of cold ethanol. 
Fluorescence was measured on a Fluoroskan II (Labsystems, Hel- 
sinki, Finland) using an excitation wavelength of 380 nm and an 
emission wavelength of 440 nm.  Fluorescence values were com- 
pared  with  a  standard  curve  prepared  with  7-amino-4-methyl- 
coumarin or 2 naphthylamide,  as described by Rivett et al.  (17). 
The  following fluorogenic  pepndes  were  used:  Suc-Leu-Leu- 
Val-Tyr-MCA  and  Suc-AIa-Ala-Phe-MCA  to  measure  chy- 
motrypsin-hke (Ch-L) activity, Cbz-Leu-Leu-Glu-2-naphthyla- 
mide  to  measure  peptidylglutamyl  peptide  hydrolyzing  activity 
(PGPH),  and  Boc-Leu-Arg-Arg-MCA to  measure  trypsin-hke 
activity (T-L).  Cruzipain activity was measured using Cbz-Phe- 
Arg-AMC as a substrate. 
Purification of T. cruzi Proteasomes.  For purification  of protea- 
somes,  T. cruzi epimastigotes (3(strain)  were used. Parasites were 
harvested from 3 1 of 6-day cultures by centrffugation at 2,000 g 
for 20 mm and washed three times with PBS. Parasites were sus- 
pended m  5 v of 20 mM Tns-HCl,  1 mM EDTA, sonlcated, and 
the  homogenate  clarified by centrffugation.  The  pellet was  dis- 
carded and the supernatant  was centrifuged at  100,000 g for 1 h. 
The  100,000  g  supernatant  was  concentrated  by  filtration  in  a 
Centricon  10  unit  (Amicon, Beverly, MA),  and  fractionated by 
fast perfomance liquid chromatography  (FPLC)  using a Superose 
6 HI< 16/50 column equilibrated with 25 mM Tris-HC1,  1 mM 
EDTA (pH 7.5).  Fractions of 1.2 ml were collected and assayed 
for Ch-L activity. The active fractions were again assayed in the 
presence of 50 IxM of either lactacystm or E-64. Those that were 
inhibited by lactacystm but not by E-64 were pooled and loaded 
onto a Mono-Q 5/5 column equilibrated with 20 mM Tris-HC1 
(pH 8.0).  Bound proteins were eluted using a 0-1M KC1 hnear 
gradient in 20 toNI Tris-HC1 (pH 8.0).  Fractmns of 0.5 ml were 
collected and assayed for proteolync acnvity as above. The active 
fractions  eluted  at  aproximately  400-500  mM  KC1.  They  were 
pooled and  concentrated  in  a  Centricon  10  umt.  The  concen- 
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brated with 25 mM Tris-HC1, 1 mM EDTA, (pH 7.5). Fractions 
of 0.6 ml were collected and assayed for Ch-L, T-L and PGPH 
activities (17). 
Protein Determination.  Protein  concentration  was  determined 
by the Bradford method (18), using BSA as a standard. 
Electrophoretic Techniques.  Samples  were  analyzed  by  SDS- 
PAGE electrophoresis according to Laemmli (19) in a  12% sepa- 
rating gel and 3% stacking gel. Two-dimensional gel SDS-PAGE 
electrophoresis was performed as in O'Farrell (20). 
Antibodies and Immunoprecipitation Studies.  Anu-T.  cruzi protea- 
some  antibodies were  obtained by injecting rabbits with  three 
doses of 50  txg of purified proteasornes using Titer Max (CytRx 
Corp, Norcross, GA) as adjuvant. The antiserum strongly reacted 
with  the  25-35  kD  proteasorne  subunits  by Western blotting. 
Two weaker unidentified bands of about 70 kD were also seen on 
the blots (data not shown). For immunoprecipitation studies, ali- 
quots of 3  X  10  ? trypornastigotes were incubated for 3 h in trans- 
formation medium alone, or in the presence oflactacystin or clasto- 
lactacystin. The  parasites  were  washed,  resuspended in  20  mM 
Tris-HCl (pH 7.5), 1 mM EDTA, and sontcated. Sonicates were 
centrifuged for 5  rain at  10,000 g.  The  supernatants were  pre- 
treated with preimrnune rabbit serum and protein A-Sepharose 
(Pharrnacia Biotech, Uppsala, Sweden), and then incubated over- 
night with anti-T,  cruzi proteasome antisera diluted 1:250.  The 
immunocornplexes were collected by incubation with 100 t~l of a 
50% suspension of protein A-Sepharose. The immunoprecipitates 
were washed and Ch-L activity measured in the presence or ab- 
sence  of protease inhibltors, as explained in the text and figure 
legends. Experiments were performed in triplicate and expressed 
as fluorescence units +  SD. 
Electron Microscopy.  Purified proteasornes (50 I~g/ml) were at- 
tached to carbon-coated and glow-discharged formvar film for 
1 nun, and subjected to negative staining with 1% uranyl acetate 
as described (21). Electron micrographs were recorded with mag- 
nificauon of 80,000 in a Zeiss EM 910 electron microscope. 
NH2-terminal Sequences.  Samples were separated on SDS-PAGE, 
transferred to  polyvinyhdene difluonde membranes  (Immobilon 
P, Millipore; Milford, MA) usrng CAPS (Sigma) pH 11, contain- 
ing 10%  (v/v)  methanol, stamed with  Coornassie blue,  and the 
protein bands  were  excised and  sequenced.  Automatic  Edrnan 
degradation analysts was camed out on a 477A protein sequencer, 
and the resulting phenylthlohydantoin derivatives idenufied using 
an online 120A phenyhhioidantoin analyser (Applied Biosystems, 
Foster City, CA). 
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Figure 1.  (A and B) Effect ofprotease inhibltors on the transformauon 
of T. cruzi trypomastlgotes into amastigotes. Parasites  were incubated for 
4 h at 37°C in transformation medtum with the protease mhlbltots, and 
then  relncubated overnight in DMEM  10%  FCS. Transformation was 
scored m  a double-bhnd  fashion by hght  microscopy, and  results ex- 
pressed as mean +  SD. 
Arg-AMC  by  recombinant  cruzain  (a  gift  from  Dr.  J+ 
McKerrow,  University of California, San  Francisco,  CA), 
or by  cruzain  purified from  parasite  extracts,  was  not  af- 
fected by high concentrations (100  txM) oflactacystin (data 
not  shown).  Conversely, parasite  remodeling was  not  af- 
fected  by  Cbz-Phe-Ala-FMK  or  Cbz-(S-Bz)Cys-Phe- 
CHN2,  cell-permeant inhibitors of cysteine proteases, or by 
E-64 at concentrations as high as 50 IxM (Fig. 1 A  and 1 B). 
The  trypomastigotes treated with  10  laM lactacystin for 
18  h  appeared  normal  on  the  basis  of motility and  mor- 
phology,  when  examined  by light microscopy  (Fig.  2  C) 
and  electron  microscopy  (data  not  shown).  Nevertheless, 
higher concentrations of lactacystin were toxic for the par- 
asite, similar to what has been described for other eukary- 
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Results 
Effect  of Protease Inhibitors  on  the  Transformation  of T.  cruzi 
in Axenic Medium.  Figs.  1  A  and  1  B  show  that  protea- 
some  inhibitors  prevented  the  transformauon  of T.  cruzi 
trypomastigotes into  amastigote-like parasites. 50%  inhibi- 
tion of transformation was achieved at 1-2  I+M concentra- 
tions  of lactacystin and  MG132,  a  peptide  aldehyde  (22) 
(Fig.  1  A).  Clasto-lactacystin dihydroxy acid,  an  inactive 
analogue  of lactacystin (Figs.  2  A  and  2  B)  (23),  did not 
prevent  transformation.  Lactacystin has  no  effect  on  cys- 
teine proteinases (24),  including cruzain (or cruzipain), the 
major lysosomal cathepsin L-like enzyme  of T.  cruzi  (25- 
27)  that has been implicated in the growth and differentia- 
tion  of the  parasite  (28-30).  The  hydrolysis of Cbz-Phe- 
C  D 
Figure  2.  Effect  of lactacystin and clasto-lactacystm on  T  cruzi. (A) 
Lactacystm. (B) Clasto-lactacystm  dlhydroxy acid. (C and D) Morphology 
of T.cruzi trypomasugotes that were incubated in DMEM (pH 5.0) m the 
presence oflactacystln or clasto-lactacystm,  respectively. 
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Figure  3.  Effect  of proteasome lnhlbltors on the expression  of stage- 
specific epltopes  of T.  cmzi  Parasites undergoing transformation m  the 
presence or absence of the proteasome lnhlbltors lactacystm (A, B, C, D), 
and MG-132 (E,  F,  G, /-/), were analyzed  by FACS ®. Trypomasugotes 
were incubated for 4 h in the transformation medmm alone or medium 
containing inhibitor, and then relncubated in DMEM  10% FCS in the 
presence (B, D, F,/-/) or absence  (A, C, E, G) oflnhibltors. At the end of 
the incubation, the parasites were washed and stained by lmmunofluores- 
cence with mAb 2C2 (A, B, E, F) or 3C9 (C, D, G, H), and analyzed by 
FACS ®. The mAb 2C2 detects Ssp-4, an amasUgote-specific epltope, and 
mAb 3C9 detects Ssp-3, a trypomasugote-spec~fic  epltope. 
OtlC  cells.  Fig.  2  D  shows  the amastigote-like  morphology 
of the parasites that had treated with clasto-lactacystin. 
The proteasome lnhibitors also delayed the expression of 
stage-specific antigens, as shown by FACS ® analysis of par- 
asite samples taken at the end of the transformation process. 
In  control  samples,  a  large  proportion  of the  amastigote- 
like  organisms  acquired  the  amastigote-specific  Ssp-4  epi- 
tope,  and  lost  the  trypomastigote-specific  Ssp-3  epitope 
(13),  while  most  parasites  incubated  with  lactacystin  or 
MG-132  retained the Ssp-3 epitope,  and were Ssp-4 nega- 
tive (Fig. 3). 
Effect of Protease  Inhibitors  on  the Intracellular  Transformation 
of T,  cruzi.  In  one  series  of experiments,  trypomastigotes 
were  preincubated with  10  IxM lactacystin or clasto-lacta- 
cystin for 1 h  at 37°C, washed by centrifugation, and added 
to  cultured  myoblasts.  The  mean  number  of intracellular 
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Figure  4.  Effect  of lactacysnn 
on  cell  invasion  by  T.  cruzi. 
L6E9-irradlated  myoblasts  were 
infected  with  trypomasUgotes 
that had been preincubated for l h 
at 37°C  with  10  txM lactacystm 
or clasto-lactacysnn. After 2 h in- 
cubation at 37°C,  the trypomas- 
tlgotes  were  removed,  and  the 
L6E9  cells  were  washed  with 
DMEM.  One  set  of  cells  was 
fixed with 4% paraformaldehyde 
in PBS for 30 ram. The extracel- 
lular trypomasUgotes were detected by lmmunofluorescence with a poly- 
c]onal antibody to  T  cruzi, and the total number of parasites was deter- 
maned by staining with Hoechst dye after permeabflization  of the L6E9 
cells with cold methanol for 10 man. The number of lntracellular parasites 
was calculated by subtracung the extracellular  from total number of para- 
sites. The remoanmg infected cell cultures  were remcubated at 37°C.  At 
24, 48, and 72 h, mphcate wells were washed and stmned with May-Gmn- 
wald-Glemsa.  The slides were exarmned under light rmcroscopy  and the 
number of lntracellular  amasugotes  in 100 cells was counted. Results are 
expressed as mean -+ SD. 
parasites  2  h  after infection was  not  significantly  different 
for trypomastigotes treated with lactacystin (41.7  +  5.4)  or 
with clasto-lactacystin (41.1  +  1.2),  indicating that protea- 
some activity was not required for cell invasion. Neverthe- 
less, at 24, 48, and 72 h  after infection the number  ofintra- 
cellular amastigotes  was  much  lower  in  cells infected with 
lactacystin-treated trypomastigotes  (Fig.  4). 
Next, we studied the effect oflactacystin on the intracel- 
lular transformation of the dividing amastigotes into trypo- 
mastigotes,  an event that occurs between  40 and 48 h  after 
infection.  In  the  following  set  of experiments,  the  myo- 
blasts were  treated  48  h  after infection with lactacystin  or 
clasto-lactacystin.  After 2  h  incubation,  the drugs were  re- 
moved,  the cells were  thoroughly washed and reincubated 
at 37°C.  At various  times  thereafter,  trypomastlgotes  were 
collected  in  the  culture  supematants  and  counted.  In  the 
A  B 
800  5000 
4000  •  Lactacys~...~  600  A 
500  3000 
400  / 
i  200 
~.  ~  1ooo 
1oo 
o  o  ,,  - 
0  0 75  1 5  3 0  80  88  916 
Concerdratlon  of Lactacylltin  (~tM)  Time  (h) 
Figure 5.  Effect oflactacystm on amasugote/trypomasUgote mtracellu- 
lar transforrnauon  L6E9 irradiated  myoblasts were infected with T. cruzt 
trypomastlgotes  At 48 h  after  infection, lactacystln  or clasto-lactacystm 
was added. After 2 h ofincubauon at 37°C,  the cultures were washed and 
relncubated at 37°C  for various  periods of time. The effect of the drugs 
on parasite development was evaluated  as follows.  (A) By counting ,n a 
Neubauer chamber the number oftrypomasugotes in the culture superna- 
tants. This was measured 48 h after removal of the drugs.  (B) By measur- 
ing translahdase acuvlty in extracts of infected cells 72, 80, 88, and 96 h 
after mfecuon, 1.e., 24,  32, 40,  and 48 h after removal of the drugs.  All 
experiments were performed m  tnphcate and values  expressed  as mean 
+  SD 
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B 
Figure 6.  Morphology of T. cmzi infected  cultures treated with lacta- 
cystm  L6E9-irra&ated  myoblasts were infected  with T. cruzi trypomas- 
txgotes. At 48 h after infection,  lactacysnn or clasto-lactacystin was added. 
After 2 h  of incubation  at 37°C,  the cultures  were washed  and  remcu- 
bated  at  37°C  for another 48  h.  The infected  cultures  were fixed  and 
stained with May-Grunwald-G]emsa and examined by light microscopy 
(A) Myoblasts  treated  with lactacystin  showing typical  amasugotes.  (B) 
Myoblasts treated wath clasto-lactacystm showing trypomasngotes  and in- 
termediate  forms. 
cultures  treated  with lactacystin  at  concentrations  of 3  and 
1.5  IzM,  significantly fewer trypomastigotes  were  released 
from  the  cells  as  compared  with  controls  treated  with 
clasto-lactacystin  or medium  alone  (Fig.  5  A).  We  also  as- 
sayed extracts  of infected cells for the presence  of transiali- 
dase,  an enzyme expressed  only in trypomastigotes.  In cul- 
tures  treated  with  clasto-lactacystin  or medium  alone,  the 
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Figure 7.  Purification and charactenzation  of T. cmzi proteasomes.  (A) 
Gel filtrat]on on Superose 6. The chymotrypsm activity in fractions 17-24 
was totally inhibited  by lactacystm but unaffected  by E-64.  (B) Amon- 
exchange chromatography  of pooled fractions 17-24  on a Mono Q  col- 
umn. Bound proteins  were eluted  using a 0-1 mM KC1 hnear  gra&ent. 
Fractions that &splayed Ch-L actlv]ty that was mhlbltable by lactacystin, 
but not by E-64, were eluted  at approxamately 400-500 mM KC1. (C) 
Gel Fdtration  on Superose 6. Fracnons eluted from the Mono Q at 400- 
500 mM KC1 were loaded onto Superose 6 16/30. Proteolytlc  activities 
under the major protein peak were measured wath the following fluoro- 
gemc peptldes:  Suc-Leu-Leu-Val-Tyr-MCA for Ch-L activity  (Ch-L), 
Boc-Leu-Arg-Arg-MCA for T-L actlvxty (T-L) and  Z-Leu-Leu-Glu- 
[JNA for peptldylglutamyl  peptide  hydrolase (PGPH). All actlvmes were 
strongly inhibited  by lactacystm but not by E-64. 
expression oftransialidase starts 80 h  after infection, and in- 
creases until the end of intracellular parasite  differentiation. 
In  lactacystin-treated  cultures,  the  expression  of transiali- 
dase  was  inhibited  (Fig.  5  B).  Finally,  one  set  of infected 
cells was stained 90 h  after infection and examined by light 
microscopy.  While 90% percent  of cells treated with lacta- 
cystin  contained  typical  amastigotes,  about  80%  of myo- 
blasts  treated  with  clasto-lactacystin  contained  trypomasti- 
gore-like or intermediate flagellate forms (Fig. 6). Analogous A 
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In wvo and m wtro mhibitaon  of T. cmzi proteasomes by lac- 
tacystm. (A). Trypomasugotes  were incubated for 3 h in transformataon 
medium containing 10  ~M  lactacystln (sohd bars), or clasto-lactacystln 
(smped bars) or with medium alone (open bars). Samples of parasites (3 × 
107) were washed with PBS, resuspended  in 200 pJ of 20 mM Trls, sonl- 
cated, and centrifuged. Supernatants  were lmmunopreclpltated  wath poly- 
clonal antxbodies raised against T.  cmzi proteasornes. Irnrnunocomplexes 
were collected usmg protean A-Sepharose, and the Ch-L actxvxty associ- 
ated with the beads was measured. When parasites were treated with me- 
dium and immunoprecipited  with preammune serum, no Ch-L activity 
was detected. (B) As additional  controls  for the specificity  of the lmmuno- 
prec~patatlon reaction, untreated parasites were sonlcated, treated with 
lactacysm (sohd bars), or clasto-lactacystm  (striped bars), or medium (open 
bars) and lrmnunoprecipltated  as above. The Ch-L actwlty of the lrnrnu- 
nopreclpxtates was then measured. All expenrnents were performed m 
tnphcate, and results expressed as mean -+ SD. 
Figure 8.  (A) Composite of SDS-PAGE (first track on the left) and 
two-dlrnenslonal  gel analysis  of T. cruzi proteasomes. The arrow points to 
an added control protean (pl 5.2). On the left are the MW markers. Gels 
were Sliver-stained.  (B) Electronnncroscopy  of T. cmzi proteasomes. Bar, 
100 nm 
experiments were  performed with  the  cell-permeant cys- 
teine proteinase inhibitors E-64d  (31)  and Cbz-Phe-Ala- 
FMK at concentrations of 10  /~M.  They had no effect on 
the  transformation of intracellular amastigotes into trypo- 
mastigotes,  or  on the  expression of transialidase (data  not 
shown). 
Identification  of the Lactacystin  Target in  T.  cruzi.  We  used 
two approaches to identify the target oflactacystin in T.  cmzi. 
First,  we  isolated the  lactacystin-inhibitable chymotrypsin 
activity from crude extracts of parasite. As shown in Fig. 7 A, 
a broad peak of chymotrypsin activity was detected follow- 
ing filtration of the extracts in a Superose 6 column. How- 
ever, only the activity in the shoulder peak (fractions  17-24), 
containing proteins of higher molecular mass,  was  inhib- 
itable by lactacystin, but not by E-64. In later fractions the 
chymotryptic activity was inhibited by E-64 but not by lac- 
tacystin.  The  lactacystin-inhibitable fractions  were  then 
subjected to  anion-exchange chromatography in a  Mono 
Q  column. A peak of chymotrypsin activity that was inhib- 
ited by lactacystin eluted at 400-450 mM of KC1 (Fig. 7 B). 
Pooled fractions from this peak were then filtered through 
another Superose 6 column. A major symmetrical OD peak 
of 670  kD  was  eluted from the  column. It contained the 
three  characteristic peptidase  activities of eukaryotic pro- 
teasomes, T-L, Ch-L, and PGPH  (Fig. 7  C). All activities 
were inhibitable by lactacystin. Using Suc-Leu-Leu-Val- 
Tyr-AMC as a substrate, the specific activity of the Ch-L 
activity was  1.5  ~M/mg/h.  At  concentrations up  to  50 
p~M, the cruzain inhibitors Cbz-Phe-Ala-FMK and Cbz- 
(S-Bz)Cys-Phe-CHN  2 did not affect the Ch-L activity of 
the purified proteasomes. 
Using SDS-PAGE under denaturing conditions the 670 kD 
molecules were resolved into subunits with molecular masses 
between 25-35 kD. By isoelectrofocusing, their isoelectric 
points varied between 4.5 and 8.5 (Fig. 8 A). The NHz-ter- 
minal protein sequence of the protein from one band (TSI- 
MAVTFKD) is identical to that of the [3-subunit of PRE3, 
a PGPH activity from yeast proteasomes (32). Electron mi- 
croscopy of negatively stained preparations revealed charac- 
teristic images ofproteasomes, i.e., hollow cylinders 18 nm 
in length and 12-15 nm in diameter (Fig. 8 B). 
To  identify the  target  of lactacystin in vivo,  we  incu- 
bated samples of trypomastigotes for 2  h  in transformation 
medium in the presence oflactacystin, clasto-lactacystin, or 
medium alone. The parasites were  washed,  and sonicated 
1914  Proteasome Control of Morphology of T. cruzi extracts were immunoprecipitated with a rabbit antiserum 
to purified T.  cruzi proteasomes, or with normal rabbit se- 
rum.  Immunoprecipitates  were  then  assayed  for  chymo- 
trypsin activity. As shown in Fig.  9 A, the immunoprecipi- 
tared proteasomes from parasites  that had been incubated 
with lactacystin were inactive. The control irnmunoprecip- 
itates from parasites  treated with medium alone or clasto- 
lactacystin had Ch-L activity that was inhibited by lactacys- 
tin, but not by E-64. No enzymatic activity was detected in 
samples  immunoprecipitated with normal rabbit serum. As 
additional controls of the specificity of the immunoprecipi- 
tation, trypomastigote extracts were treated with lactacystin 
or  clasto-lactacystin and  then  immunoprecipitated  as  de- 
scribed  above.  The  immunoprecipitates  originating from 
extracts treated with lactacystin were inactive (Fig. 9 B) 
Discussion 
We  show here that  the  proteasome inhabitors  MG132 
and lactacystin prevented the transformation of trypomas- 
tigotes into amastigotes an axenic medium. MG132, a pep- 
tide aldehyde, also potently inhibits cysteine proteases, but 
lactacystin selectively inhibits the peptidase activity of pro- 
teasomes. The transient intermediate of lactacystin, clasto- 
lactacystin 13 lactone, binds tightly to threonines in the active 
site of the [3 subunits ofproteasomes (24, 33). Clasto-lacta- 
cystin dihydroxy acid (Fig.  2 B), the product of hydrolysis 
of the active 13 lactone, had no activity in parasite transfor- 
mation. Lactacystin does not inhibit serine or cysteine pro- 
teases of mammalian cells (24), and did not affect the activ- 
aty of cruzain,  the  major  T.  cruzi  lysosomal enzyme. We 
further ascertained that proteasomes are the targets of lacta- 
cystin in trypomastigotes by two independent criteria. First, 
proteasomes were isolated to apparent homogeneity from 
crude extracts of parasites  using a lactacystin-based assay to 
follow purification.  Second,  while immunoprecipitates of 
proteasomes present in extracts of clasto-lactacystin-treated 
parasites  had  Ch-L  activity, the  immunoprecipitates from 
lactacystin-treated parasites  were inactive. 
We also studied the effect oflactacystin on the infectivity 
of T.  cmzi trypomastigotes to myoblasts.  In these experi- 
ments, we tried to minimize or exclude possible effects of 
the drug on the target cells.  For example, when studying 
the attachment and penetration phases of infection, drug- 
treated parasites  were washed before incubation with  the 
myoblasts. We found that lactacystin had no effect on inva- 
sion,  an  active process that  requires parasite  energy (34), 
and is  associated with  calcium fluxes in  the parasite  (35). 
However, the intracellular development of the lactacystin- 
treated parasites  was  arrested.  It cannot be  deduced from 
these results whether lactacystin inhibited only the trypo- 
mastigote/amastigote  transformation.  There  is  a  distinct 
possibility that lactacystin inhibited amastigote proliferation 
as well, since the eukaryotic cell cycle is regulated by pro- 
teasomes. In any case, these experiments also show that the 
effects oflactacystin persisted during the intracellular devel- 
opment of the parasite. Lactacystin is an irreversible inhibi- 
tor ofproteasomes, and the half-life of T. cruzi proteasomes 
may be long. Alternatively, drug treatment may have irre- 
versibly affected a proteasome-dependent essential  parasite 
function. 
Lactacystin also prevented the transformation of amasti- 
gotes into trypomastigotes that occurs at the end of the in- 
tracellular phase.  In these experiments, myoblasts infected 
48 h previously with trypomastigotes were exposed for 2 h 
to 1-3 p~M of lactacystin. The effect was striking: as com- 
pared with  clasto-lactacystin-treated cells,  the  lactacystin- 
treated cells released fewer trypomastigotes into the culture 
medium,  contained more  amastigotes  in  their  cytoplasm, 
and displayed much less  transialidase  activity. In  contrast, 
higher concentrations of cell-permeant inhibitors of crnzi- 
pain had no effect on the amastigote/trypomastigote trans- 
formation. The small concentrations oflactacystin used, the 
short durataon of drug treatment, the specificity of the ob- 
served effects, and the lack of effect of cysteine protease in- 
hibitors argue strongly that the prime targets of lactacystin 
are the transforming parasites  rather than the myoblasts. 
These results show that proteasome activity is necessary 
for remodeling, but  the  substrates  that are degraded have 
not  been identified.  They probably include  proteins  that 
maintain the old shape, most likely cytoskeletal elements, 
a set of proteins and enzymes involved in the old meta- 
bolic pathways, and stage-specific surface proteins. In addi- 
tion to these housekeeping functions, the cleavage of key 
regulatory proteins by proteasomes may provide the cen- 
tral  switching  mechanism  that  initiates  the  stage-specific 
changes (36). 
In eukaryotic cells,  the substrates  destined for degrada- 
tion are recognized by specific E2-E3 Ub-protein ligases 
(37).  However, very little is known about the Ub-protea- 
some system in protozoan parasites.  Southern and North- 
ern blots of DNA and RNA from various strains of T. cruzi 
revealed large variations in the number of Ub  genes (38). 
Its  genome  may  contain  more  than  100  Ub  coding  se- 
quences,  a number much larger than in  other organisms. 
These are encoded in five polyUb genes and five Ub fusion 
genes,  whose  transcription  is  altered  under  stress  condi- 
taons. There is a significant increase in steady-state levels of 
Ub mRNA between the midlog phase cultures of nonin- 
fective epimastigotes of T.  cruzi,  and the  stationary phase 
cultures that contain the morphologically distinct, infective 
metacyclics (39). It is noteworthy that heat-shock elements 
are present in the intergenic regions preceding the polyUb 
genes. Perhaps the expression of the Ub genes in T. cruzi is 
regulated by the shifts in environmental pH and tempera- 
ture, and by other stress conditions that lead to stage-spe- 
cific remodeling.  In yeasts  that bear mutations  in protea- 
somes,  sensitwity  to  stress  is  increased,  and  under  stress 
conditions the mutants accumulate ubiqmtinated proteins. 
Other proteases have been identified in T. cruzi (40-42). 
One of them, cruzain, a lysosomal cathepsin L-like cysteine 
protease, also plays  a role in growth and differentiation of 
the parasate  (28-30).  Studies in different laboratories have 
shown that synthetic inhibitors of cruzain, including Cbz- 
1915  Gonzfilez  et al. Phe-Ala-FMK  and  Cbz-(S-Bz)Cys-Phe-CHN2,  inhibit 
T. cruzi infectivity. However, different from lactacystin, the 
cysteine  protease  inhibitors  prevent  parasite  penetration 
into  the  heart  muscle  cells  (28).  As shown  here,  relatively 
high  concentrations  of Cbz-Phe-Ala-FNIK  and  Cbz-(S- 
Bz)-Cys-Phe-CHN2  did  not  affect the  remodeling  of T. 
cruzi in axenic medium or inside  cells. Although  our find- 
ings do not exclude a role for cruzain and other lysososmal 
enzymes in the  extensive proteolysis that must accompany 
remodeling,  they argue that the role of cruzain is not piv- 
otal during these phases of parasite development. 
Some publications report the presence ofproteasomes in 
Trypanosoma (43, 44) and Entamoeba (45), but their function 
has not been studied.  We found that the structural  features 
and architecture  of the  T.  cruzi proteasomes were  similar 
to  those  of other  species.  By  SDS-PAGE  the  cylindrical 
20S  structure  was  resolved  into  the  typical  6-8  bands  of 
25-35  kD.  However,  more than  20 proteins,  with  widely 
diverse pls, were seen in  T.  cruzi proteasornes  analyzed by 
two-dimensional PAGE.  It as generally accepted that the 20S 
proteasorne is a dimer of 14 subunits arranged otT[37137oL  7. In 
the yeast Saccharomyces cerevisiae there are fourteen genes en- 
coding  7  ot and  7  [3  subunits,  and  the  dendrogram  repre- 
senting  the  alignments  of all  eukaryotic  proteasome  se- 
quences yields only 14 subgroups  containing  a  single yeast 
member. The explanation for the large number of T. cruzi 
proteasome-associated  proteins  may be  trivial:  some  extra 
spots  could  represent  posttranslational  modifications  of a 
polypeptide,  or simply contaminants.  Alternatively,  an un- 
usual  feature  of T.  cruzi  is  that  its  proteins  are  frequently 
encoded by several tandemly arranged genes that are poly- 
clstronically  transcribed  from  a  single  promoter  and  are 
concurrently  expressed.  Sequence  variation of genes found 
in  one  such  transcription  unit  could  add  to  the  apparent 
subunit heterogeneity.  Further studies are necessary to clar- 
ify this issue. 
The present paper demonstrates that proteasome activity 
is  essential  for  T.  cruzi  remodeling.  Very  similar  results 
were recently obtained with other protozoan parasites. In a 
rodent malaria model Sinnis,  P., B.  Gutierrez,  M.  Briones, 
and V. Nussenzwerg (manuscript in preparation) showed that 
lactacystin  did  not  prevent  the  penetration  of the  Plasmo- 
dium  berghei crescent-shaped  sporozoites  into  hepatocytes, 
but  strongly inhibited  their  transformation  into  the  round 
hepatocyte  stages and subsequent  development.  Eichinger, 
D., V. Nussenzweig, and J. Gonzalez (manuscript in prepa- 
ration)  demonstrated that lactacystin prevented the encysta- 
tion  of Entamoeba  invadens.  Trypanosoma,  Entamoeba,  and 
Plasmodium belong to phyla widely separated in evolution. 
Therefore, it is likely that the mechanisms governing stage- 
specific morphological  changes  in  protozoa  are  conserved, 
and proteasome-dependent,  and that proteasome inhibltors 
may have a broad range of targets. Encouraging features for 
attempting  to  develop  this  class  of chemotherapic  agents 
are that some parasites,  such  as  Plasmodium,  undergo  con- 
stant  and  rapid remodeling  in the  mammalian  host.  Thus, 
effective drugs need not be administered for prolonged pe- 
riods  of time to arrest parasite  development.  Furthermore, 
the accurate  discrimination  between the old and new pro- 
teins that coexist within the same cell during remodeling of 
protozoa  may  require  specialized  features  of the  protea- 
some/Ub system. Proteasomes from intracellular protozoan 
parasites may also differ significantly in structure from those 
of the  host  cell,  rendering  the  infected  cells susceptible  to 
destruction  by  cells  of  the  immune  system.  Hopefully, 
some  of these  approaches  to  therapy  will  yield  to  experi- 
mental attack. 
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